CHEVALLEREAU Anne NB

Anne Chevallereau

Host Institution

Group leader, CNRS Researcher (CR)

Current position

Institut de Biologie et Chimie des Protéines, Lyon ; CNRS

anne.chevallereau@cnrs.fr

Colorized scanning electron microscopy photo. Lysis of Acinetobacter baumannii bacteria by phage vB-GEC_Ab-M-G7 (©L. Debarbieux, Institut Pasteur; M. and C. Rohde, Helmholtz Centre for Infection Research)

Coevolution of bacteria and their viruses

 

Anne Chevallereau and her research group are investigating how pathogenic bacteria interact and evolve with their viruses, also known as bacteriophages, which are foreseen as a valuable therapeutic option to treat bacterial infections. They study how bacteria can become resistant to bacteriophages and reciprocally, how bacteriophages can escape resistance. In particular, they explore the role of defence systems ( specific mechanisms that bacteria have developed to fend off bacteriophage infection), how their activity depends on the environment in which bacteria are growing and how these defence systems can be exchanged between bacteria.

They use the pathogen Pseudomonas aeruginosa and Escherichia coli as models, which are amongst the most problematic bacteria in the context of antibiotic crisis.


Read more


Training

• 2019 PhD, Faculty of Medicine, Ludwig-Maximilians University Munich, Germany, Advisor: Prof. Dr. Anton Sirota

• 2018 - 2022 EMBO LTF and MSCA IF postdoctoral research fellow, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland, Advisor: Prof. Dr. Andreas Lüthi

• 2022-2023 SNSF Ambizione team leader, Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland

• 2024: Team leader, Neuronal Circuits & Brain Dynamics Lab, Paris Brain Institute, France

Awards

• European Research Council (ERC) Starting Grant, 2024

• ATIP-Avenir, 2024

• BBRF NARSAD, 2024

• Swiss National Foundation Ambizione, 2022

• Marie Curie Individual Fellowship, 2021

• EMBO Long-Term Fellowship, 2019